{"id":196793,"date":"2024-09-29T23:23:09","date_gmt":"2024-09-30T04:23:09","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2024\/09\/overcoming-treatment-challenges-in-multiple-myeloma-bispecific-antibodies-and-car-t-cell-therapy"},"modified":"2024-09-29T23:23:09","modified_gmt":"2024-09-30T04:23:09","slug":"overcoming-treatment-challenges-in-multiple-myeloma-bispecific-antibodies-and-car-t-cell-therapy","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2024\/09\/overcoming-treatment-challenges-in-multiple-myeloma-bispecific-antibodies-and-car-t-cell-therapy","title":{"rendered":"Overcoming Treatment Challenges in Multiple Myeloma: Bispecific Antibodies and CAR T-Cell Therapy"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/overcoming-treatment-challenges-in-multiple-myeloma-bispecific-antibodies-and-car-t-cell-therapy.jpg\"><\/a><\/p>\n<p>Immunotherapies are the cornerstone of treatment for multiple myeloma (MM), demonstrating clinically meaningful improvements in response rates and progression-free survival (PFS) through the use of more precise, targeted therapies.<\/p>\n<hr>\n<p>Experts discuss immunotherapy advancements and challenges of resistance, efficacy, and toxicity in patient management.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Immunotherapies are the cornerstone of treatment for multiple myeloma (MM), demonstrating clinically meaningful improvements in response rates and progression-free survival (PFS) through the use of more precise, targeted therapies. Experts discuss immunotherapy advancements and challenges of resistance, efficacy, and toxicity in patient management.<\/p>\n","protected":false},"author":534,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-196793","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/196793","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/534"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=196793"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/196793\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=196793"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=196793"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=196793"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}